NIH-funded research R01 grant

Understanding TBCD gene variations and developing new treatments for related brain disorders

Official title: Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy

Funded at Research Inst Nationwide Children's Hosp · NIH-11015788 · Data updated 2026-11-12

This study is looking at how changes in the TBCD gene affect children with severe developmental and epileptic encephalopathy, using special cells and mouse models to better understand the disease and find new ways to help those who are affected.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$568,866
NIH project number5R01NS134923-02
Project IDNIH-11015788 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with TBCD-related developmental and epileptic encephalopathy.

Less likely to help

Patients with other forms of encephalopathy unrelated to TBCD gene variations may not benefit from this research.

What this research studies

This research investigates the effects of variations in the TBCD gene, which can lead to severe developmental and epileptic encephalopathy in children. By utilizing induced pluripotent stem cells and cerebral organoids derived from patients, the team aims to uncover the underlying mechanisms of the disease and assess how different genetic variants affect disease progression. The research also includes the development of mouse models to study the impact of TBCD deficiency on neurodevelopment. Through these approaches, the project seeks to identify potential therapeutic strategies to improve outcomes for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve the quality of life for patients with TBCD-related encephalopathy.

How similar studies have gone: Previous research has shown promise in using stem cell models to study genetic disorders, indicating that this approach could yield valuable insights.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Bradbury, Allison M — Research Inst Nationwide Children's Hosp
  • Study coordinator: Bradbury, Allison M

Related research

Other NIH-funded projects on the same topics.

  • A center focused on immunotherapy for pediatric cancers.

    This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-9839924

  • Atomoxetine for MC4R obesity in children

    A trial tests whether an ADHD drug, atomoxetine, can help children with a genetic form of obesity caused by MC4R mutations.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-11586252

  • Collaborative Pediatric Critical Care Network: Clinical Site

    A nationwide network study aims to tailor sepsis treatment for children with organ failure based on each child’s immune profile.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-11561444

  • How dietary fats may make platelets overactive in obesity

    A study in adults with obesity will explore how saturated fats in the diet change platelet membranes and make platelets act more likely to clump and react, which could affect heart and blood vessel health.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-11552937

  • Understanding how environment and microbiome affect health in children with sickle cell disease

    A research project will explore how environmental exposures shape immune responses and airway microbiomes in children with sickle cell disease and how these factors relate to health outcomes.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-11515703

  • Pediatric cancer biospecimen bank and research collaboration fund

    This grant supports the Children’s Oncology Group to collect, bank, and share tumor and other biospecimens from children and adolescents with cancer for research.

    NIH research Research Inst Nationwide Children's Hosp · Columbus, United States · NIH-11513190

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.